目的：评价家庭内肺康复锻炼对COPD 患者年急性加重次数和生活质量的影响。方法：采用随机对照法，将正在接受稳定期药物治疗的COPD 患者分为治疗组和对照组，治疗A 组给予健康教育和家庭内肺康复训练，治疗B 组给予健康教育和家庭内肺康复训练联合穴位贴敷治疗，对照组给予健康教育,干预时间为1 年；观察患者的年急性加重次数和生活质量变化。结果：患者接受家庭内肺康复锻炼一年后，与入组前相比，治疗A 组和B 组患者急性加重（AECOPD）次数显著减少（P约0.01），OR 值分别是（0.79,2.02），（0.59,2.11）；A 组和B 组的生活质量明显提高（P 约0.05），OR 分别是（3.39,10.11），（4.23,9.57）；对照组生活质量明显提高（P约0.05），OR 值（0.42,5.00）。与对照组相比，B 组生活质量明显改善（P约0.05），OR 值为（0.59,7.78）。结论：家庭内肺康复锻炼可减少COPD 患者的急性加重次数，改善患者的生活质量，降低COPD 患者未来风险，可进行临床和社区推广。

This study was aimed to evaluate the number of acute exacerbation of chronic obstructive pulmonary disease (COPD) and quality of life with family pulmonary rehabilitation exercise. Randomized controlled method was used in the study. The COPD patients in the stability drug treatment were divided into the treatment group and control group. The treatment group A was given health education and pulmonary rehabilitation training in the family. And the treatment group B was given health education and treatment of pulmonary rehabilitation training in the family with acupoint application therapy. Health education was given in the control group. Changes on the number of acute exacerbation of COPD and quality of life were observed. The intervention time was one year. The results showed that patients after one-year pulmonary rehabilitation exercise in the family, the acute exacerbation(AECOPD) times of treatment group A and group B were obviously decreased (P < 0.01) compared to pre -treatment. The OR value was (0.79, 2.02) and (0.59, 2.11), respectively. The quality of life of treatment group A and group B was obviously improved (P < 0.05). The OR value was (3.39, 10.11) and (4.23, 9.57), respectively. Compared to the control group, the quality of life in treatment group B was obviously improved (P < 0.05). The OR value was (0.59, 7.78). It was concluded that the pulmonary rehabilitation exercise in the family can decrease the number of AECOPD and improve the quality of life of patients, reduce the risk of COPD patients in the future. This method is worth popularizing in the clinical and community practice.

新疆维吾尔自治区科技厅科技攻关计划（201233139）：中医药预防慢性阻塞性肺疾病急性发作的临床研究，负责人：李风森。